These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11781072)

  • 1. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
    Lin CM; Wang FH; Lee PK
    Clin Immunol; 2002 Jan; 102(1):96-105. PubMed ID: 11781072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tolerance by IL-10-treated dendritic cells.
    Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
    J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
    Sung JL; Lin JT; Gorham JD
    Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
    Abediankenari S; Ghasemi M
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.
    Kobie JJ; Wu RS; Kurt RA; Lou S; Adelman MK; Whitesell LJ; Ramanathapuram LV; Arteaga CL; Akporiaye ET
    Cancer Res; 2003 Apr; 63(8):1860-4. PubMed ID: 12702574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.
    Ghiringhelli F; Puig PE; Roux S; Parcellier A; Schmitt E; Solary E; Kroemer G; Martin F; Chauffert B; Zitvogel L
    J Exp Med; 2005 Oct; 202(7):919-29. PubMed ID: 16186184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
    Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
    Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
    Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
    Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
    Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
    Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.
    Zhang X; Kedl RM; Xiang J
    Biochem Biophys Res Commun; 2009 Feb; 379(4):954-8. PubMed ID: 19135981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.